UBS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UBS and other ETFs, options, and stocks.

About UBS

UBS Group AG is a holding company, which engages in the provision of financial management solutions. It operates through the following segments: Global Wealth Management, Personal and Corporate Banking, Asset Management, Investment Bank, Non-Core and Legacy, and Group Items. 

CEO
Sergio P. Ermotti
CEOSergio P. Ermotti
Employees
103,177
Employees103,177
Headquarters
Zurich, Zurich
HeadquartersZurich, Zurich
Founded
1998
Founded1998
Employees
103,177
Employees103,177

UBS Key Statistics

Market cap
148.98B
Market cap148.98B
Price-Earnings ratio
15.63
Price-Earnings ratio15.63
Dividend yield
1.18%
Dividend yield1.18%
Average volume
2.16M
Average volume2.16M
High today
$45.80
High today$45.80
Low today
$45.24
Low today$45.24
Open price
$45.66
Open price$45.66
Volume
2.39M
Volume2.39M
52 Week high
$49.36
52 Week high$49.36
52 Week low
$30.36
52 Week low$30.36

Stock Snapshot

UBS(UBS) stock is priced at $45.25, giving the company a market capitalization of 148.98B. It carries a P/E multiple of 15.63 and pays a dividend yield of 1.2%.

During the trading session on 2026-05-17, UBS(UBS) shares reached a daily high of $45.80 and a low of $45.24. At a current price of $45.25, the stock is +0.0% higher than the low and still -1.2% under the high.

Trading volume for UBS(UBS) stock has reached 2.39M, versus its average volume of 2.16M.

The stock's 52-week range extends from a low of $30.36 to a high of $49.36.

The stock's 52-week range extends from a low of $30.36 to a high of $49.36.

UBS News

Simply Wall St 6h
Does Corcept Therapeutics' UBS Upgrade and Insider Gifting Reframe Its Oncology Ambitions? - simplywall.st

...

Does Corcept Therapeutics' UBS Upgrade and Insider Gifting Reframe Its Oncology Ambitions? - simplywall.st
Seeking Alpha 4d
Corcept Therapeutics climbs on UBS upgrade

Corcept Therapeutics (CORT) jumped more than 7% on Wednesday after the stock was upgraded to Buy from Neutral by UBS Group. The brokerage firm also raised its...

Corcept Therapeutics climbs on UBS upgrade
TipRanks 5d
UBS Group Ceases to Be Substantial Shareholder in Nanosonics

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

45%

of 20 ratings
Buy
40%
Hold
45%
Sell
15%

People also own

Based on the portfolios of people who own UBS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.